文献速递肿瘤 PET/CT核素与放射性配体治疗

慢性髓性白血病髓外及髓内原始细胞危象的18F-FDG PET/CT检测与疗效评估

Detection and Response Evaluation of Extramedullary and Medullary Blast Crisis in Chronic Myeloid Leukemia on 18 F-FDG PET/CT.
PubMed 文献 · Clin Nucl Med · 2024-10-02

本文报道一例酪氨酸激酶抑制剂治疗下BCR-ABL1定量逆转录聚合酶链反应提示疾病控制的慢性髓性白血病患者,因近期视力下降伴视网膜下渗出接受PET/CT,检出FDG高摄取鼻窦黏膜增厚及双侧骨髓病变,组织病理证实为髓外及髓内原始细胞危象,经类固醇及更换酪氨酸激酶抑制剂治疗后复查PET/CT显示形态学与代谢缓解。

要点

  • 慢性髓性白血病患者PET/CT非常规开展,本例因视力下降伴视网膜下渗出而行PET/CT。
  • PET/CT检出FDG高摄取鼻窦黏膜增厚及双侧骨髓病变,病理证实为髓外及髓内原始细胞危象。
  • 治疗后复查PET/CT可显示病变形态学与代谢缓解。

核心结论

  • 本例提示FDG PET/CT可检出慢性髓性白血病患者的髓外及髓内原始细胞危象,并可用于后续疗效评估。

研究设计与样本

  • 本文为个案报道,报道一例接受酪氨酸激酶抑制剂治疗、BCR-ABL1定量逆转录聚合酶链反应提示疾病控制的慢性髓性白血病患者。

主要发现

  • 患者因近期视力下降、眼科检查见视网膜下渗出而行PET/CT,检出FDG高摄取鼻窦黏膜增厚及双侧骨髓病变。
  • 上述病变经组织病理采样检查证实为髓外及髓内慢性髓性白血病原始细胞危象。
  • 患者随后接受类固醇治疗并更换酪氨酸激酶抑制剂以治疗慢性髓性白血病原始细胞危象。
  • 后续FDG PET/CT显示病变形态学与代谢缓解。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

FDG PET/CT imaging is usually not routinely undertaken in patients of chronic myeloid leukemia (CML). We present a case of CML on tyrosine kinase inhibitor treatment with disease control indicated by BCR-ABL1 quantitative reverse transcription-polymerase chain reaction, who underwent PET/CT for evaluation of recent onset vision deterioration with subretinal exudates on ophthalmological examination. PET CT detected FDG-avid sinonasal thickening and bilateral marrow lesions. These lesions on histopathological sampling, examination revealed extramedullary and intramedullary CML blast crisis. Patient was then treated with steroids and change of tyrosine kinase inhibitor for the CML blast crisis. FDG PET/CT done subsequently was able to demonstrate morphological and metabolic response in the lesions.

来源:Clin Nucl Med,查看原文。版权归原作者所有。

引用

  1. Behera A, Prabhu M, Khanna G, et al. Detection and Response Evaluation of Extramedullary and Medullary Blast Crisis in Chronic Myeloid Leukemia on 18 F-FDG PET/CT. Clin Nucl Med. 2024. PMID: 39354689. doi:10.1097/RLU.0000000000005451

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。